2637 — Fujian Haixi Pharmaceuticals Co Cashflow Statement
0.000.00%
Last trade - 00:00- HK$19.06bn
- HK$19.19bn
- CNY582.36m
Annual cashflow statement for Fujian Haixi Pharmaceuticals Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | 73.8 | 133 | 149 | 198 |
| Depreciation | ||||
| Non-Cash Items | 18.2 | 1.52 | 0.414 | -7.32 |
| Unusual Items | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | -9.47 | 8.88 | 9.55 | -38.6 |
| Change in Accounts Receivable | ||||
| Change in Inventories | ||||
| Change in Payable / Accrued Expenses | ||||
| Change in Other Liabilities | ||||
| Other Operating Cash Flow | ||||
| Cash from Operating Activities | 85.3 | 147 | 164 | 160 |
| Capital Expenditures | -31.7 | -59.5 | -179 | -44.9 |
| Purchase of Fixed Assets | ||||
| Purchase / Acquisition of Intangibles | ||||
| Other Investing Cash Flow Items | -22.1 | 46.7 | -200 | -434 |
| Sale/Maturity of Investment | ||||
| Purchase of Investments | ||||
| Other Investing Cash Flow | ||||
| Cash from Investing Activities | -53.8 | -12.8 | -379 | -479 |
| Financing Cash Flow Items | 143 | -10.1 | -14.3 | -45.8 |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | 133 | -51.5 | -1.27 | 931 |
| Foreign Exchange Effects | ||||
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | 165 | 82.8 | -216 | 607 |